Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord

Pain. 2004 Jun;109(3):308-318. doi: 10.1016/j.pain.2004.01.034.

Abstract

Nicotinic agonists have well-documented antinociceptive properties when administered subcutaneously or intrathecally in mice. However, secondary mild to toxic effects are observed at analgesic doses, as a consequence of the activation of the large family of differentially expressed nicotinic receptors (nAChRs). In order to elucidate the action of nicotinic agonists on spinal local circuits, we have investigated the expression and function of nAChRs in functionally identified neurons of neonate mice spinal cord. Molecular markers, amplified at the single-cell level by RT-PCR, distinguished two neuronal populations in the dorsal horn of the spinal cord: GABAergic/glycinergic inhibitory interneurons, and calbindin (CA) or NK1 receptor (NK1-R) expressing, excitatory interneurons and projection neurons. The nicotinic response to acetylcholine of single cells was examined, as well as the pattern of expression of nAChR subunit transcripts in the same neuron. Beside the most expressed subunits alpha4, beta2 and alpha7, the alpha2 subunit transcript was found in 19% of neurons, suggesting that agonists targeting alpha2* nAChRs may have specific actions at a spinal level without major supra-spinal effects. Both inhibitory and excitatory neurons responded to nicotinic stimulation, however, the nAChRs involved were markedly different. Whereas GABA/glycine interneurons preferentially expressed alpha4alpha6beta2* nAChRs, alpha3beta2alpha7* nAChRs were preferentially expressed by CA or NK1-R expressing neurons. Recorded neurons were also classified by firing pattern, for comparison to results from single-cell RT-PCR studies. Altogether, our results identify distinct sites of action of nicotinic agonists in circuits of the dorsal horn, and lead us closer to an understanding of mechanisms of nicotinic spinal analgesia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Afferent Pathways / drug effects*
  • Afferent Pathways / physiology
  • Analgesics / pharmacology*
  • Animals
  • Biomarkers
  • Calbindins
  • Dendrites / drug effects
  • Dendrites / physiology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Glycine / metabolism
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C57BL
  • Neural Inhibition / drug effects
  • Neural Inhibition / physiology
  • Nicotine / pharmacology*
  • Nociceptors / drug effects*
  • Nociceptors / physiology
  • Pain / drug therapy*
  • Pain / physiopathology
  • Posterior Horn Cells / drug effects*
  • Posterior Horn Cells / physiology
  • Protein Subunits / drug effects
  • Protein Subunits / metabolism
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Receptors, Neurokinin-1 / genetics
  • Receptors, Nicotinic / drug effects
  • Receptors, Nicotinic / metabolism
  • S100 Calcium Binding Protein G / genetics
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Analgesics
  • Biomarkers
  • Calbindins
  • Protein Subunits
  • RNA, Messenger
  • Receptors, Neurokinin-1
  • Receptors, Nicotinic
  • S100 Calcium Binding Protein G
  • gamma-Aminobutyric Acid
  • Nicotine
  • Glycine